328 related articles for article (PubMed ID: 15877763)
21. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
[TBL] [Abstract][Full Text] [Related]
23. Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question.
Smeeth L; Hall AJ; Rodrigues LC; Huang X; Smith PG; Fombonne E
BMJ; 2001 Jul; 323(7305):163; author reply 164. PubMed ID: 11463692
[No Abstract] [Full Text] [Related]
24. Vaccines and the changing epidemiology of autism.
Taylor B
Child Care Health Dev; 2006 Sep; 32(5):511-9. PubMed ID: 16919130
[TBL] [Abstract][Full Text] [Related]
25. Early exposure to the combined measles-mumps-rubella vaccine and thimerosal-containing vaccines and risk of autism spectrum disorder.
Uno Y; Uchiyama T; Kurosawa M; Aleksic B; Ozaki N
Vaccine; 2015 May; 33(21):2511-6. PubMed ID: 25562790
[TBL] [Abstract][Full Text] [Related]
26. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Geier DA; Geier MR
Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
[TBL] [Abstract][Full Text] [Related]
27. [Mumps in Poland in 2006].
Stefanoff P; Rogalska J
Przegl Epidemiol; 2008; 62(2):225-8. PubMed ID: 18807461
[TBL] [Abstract][Full Text] [Related]
28. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis.
Kaye JA; del Mar Melero-Montes M; Jick H
BMJ; 2001 Feb; 322(7284):460-3. PubMed ID: 11222420
[TBL] [Abstract][Full Text] [Related]
29. [Rubella in Poland in 2005].
Czarkowski MP; Stefanoff P
Przegl Epidemiol; 2007; 61(2):199-206. PubMed ID: 17956032
[TBL] [Abstract][Full Text] [Related]
30. Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.
Hviid A; Hansen JV; Frisch M; Melbye M
Ann Intern Med; 2019 Apr; 170(8):513-520. PubMed ID: 30831578
[TBL] [Abstract][Full Text] [Related]
31. Causal link between MMR vaccination and autism: fact or fiction?
Christie CD
West Indian Med J; 2000 Dec; 49(4):266-7. PubMed ID: 11211531
[No Abstract] [Full Text] [Related]
32. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
33. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.
Taylor B; Miller E; Lingam R; Andrews N; Simmons A; Stowe J
BMJ; 2002 Feb; 324(7334):393-6. PubMed ID: 11850369
[TBL] [Abstract][Full Text] [Related]
34. Measles, mumps, and rubella (MMR) vaccine and autism. Argument is too simplistic.
Edwardes M; Baltzan M
BMJ; 2001 Jul; 323(7305):163; author reply 164. PubMed ID: 11484721
[No Abstract] [Full Text] [Related]
35. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
Bernsen RM; van der Wouden JC
Pediatr Allergy Immunol; 2008 Sep; 19(6):544-51. PubMed ID: 18266826
[TBL] [Abstract][Full Text] [Related]
36. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
[TBL] [Abstract][Full Text] [Related]
37. Modeling clinical outcome of children with autistic spectrum disorders.
Coplan J; Jawad AF
Pediatrics; 2005 Jul; 116(1):117-22. PubMed ID: 15995041
[TBL] [Abstract][Full Text] [Related]
38. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.
Jacobsen SJ; Ackerson BK; Sy LS; Tran TN; Jones TL; Yao JF; Xie F; Cheetham TC; Saddier P
Vaccine; 2009 Jul; 27(34):4656-61. PubMed ID: 19520201
[TBL] [Abstract][Full Text] [Related]
39. Does measles-mumps-rubella (MMR) vaccination cause inflammatory bowel disease and autism?
Strauss B; Bigham M
Can Commun Dis Rep; 2001 Apr; 27(8):65-72. PubMed ID: 11338656
[No Abstract] [Full Text] [Related]
40. No evidence for a new variant of measles-mumps-rubella-induced autism.
Fombonne E; Chakrabarti S
Pediatrics; 2001 Oct; 108(4):E58. PubMed ID: 11581466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
